Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally avai...
Industry: Biotechnology
Sector: Healthcare
Phone: 862 703 7170
Fax: 908 237 0071
Address:
200 Route 31 North, Suite 104, Flemington, United States
